| Cognitive decline in Parkinson disease D Aarsland, B Creese, M Politis, KR Chaudhuri, DH Ffytche, D Weintraub, ... Nature Reviews Neurology 13 (4), 217-231, 2017 | 1035 | 2017 |
| The psychosis spectrum in Parkinson disease DH Ffytche, B Creese, M Politis, KR Chaudhuri, D Weintraub, C Ballard, ... Nature Reviews Neurology 13 (2), 81-95, 2017 | 342 | 2017 |
| Loneliness, physical activity, and mental health during COVID-19: a longitudinal analysis of depression and anxiety in adults over the age of 50 between 2015 and 2020 B Creese, Z Khan, W Henley, S O’Dwyer, A Corbett, MV Da Silva, K Mills, ... International psychogeriatrics 33 (5), 505-514, 2021 | 214 | 2021 |
| Mild behavioral impairment as a marker of cognitive decline in cognitively normal older adults B Creese, H Brooker, Z Ismail, KA Wesnes, A Hampshire, Z Khan, ... The American Journal of Geriatric Psychiatry 27 (8), 823-834, 2019 | 176 | 2019 |
| Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality C Ballard, B Creese, A Corbett, D Aarsland Expert opinion on drug safety 10 (1), 35-43, 2011 | 155 | 2011 |
| Treatment of behavioral and psychological symptoms of Alzheimer’s disease A Corbett, J Smith, B Creese, C Ballard Current treatment options in neurology 14, 113-125, 2012 | 98 | 2012 |
| Psychosis in Alzheimer disease—mechanisms, genetics and therapeutic opportunities Z Ismail, B Creese, D Aarsland, HC Kales, CG Lyketsos, RA Sweet, ... Nature Reviews Neurology 18 (3), 131-144, 2022 | 96 | 2022 |
| Profile of mild behavioral impairment and factor structure of the Mild Behavioral Impairment Checklist in cognitively normal older adults B Creese, A Griffiths, H Brooker, A Corbett, D Aarsland, C Ballard, Z Ismail International psychogeriatrics 32 (6), 705-717, 2020 | 79 | 2020 |
| Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: review and meta‐analyses B Creese, E Bell, I Johar, P Francis, C Ballard, D Aarsland American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 177 …, 2018 | 71 | 2018 |
| Validation of the Cohen-Mansfield agitation inventory observational (CMAI-O) tool AW Griffiths, CP Albertyn, NL Burnley, B Creese, R Walwyn, I Holloway, ... International psychogeriatrics 32 (1), 75-85, 2020 | 60 | 2020 |
| Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease B Creese, Z Ismail Alzheimer's research & therapy 14, 1-5, 2022 | 57 | 2022 |
| Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults B Creese, R Arathimos, H Brooker, D Aarsland, A Corbett, C Lewis, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13 (1 …, 2021 | 57 | 2021 |
| Revisiting criteria for psychosis in Alzheimer’s disease and related dementias: toward better phenotypic classification and biomarker research CE Fischer, Z Ismail, JM Youakim, B Creese, S Kumar, N Nuñez, ... Journal of Alzheimer's disease 73 (3), 1143-1156, 2020 | 53 | 2020 |
| Evaluating the effectiveness and cost-effectiveness of Dementia Care Mapping™ to enable person-centred care for people with dementia and their carers (DCM-EPIC) in care homes … CA Surr, REA Walwyn, A Lilley-Kelly, R Cicero, D Meads, C Ballard, ... Trials 17, 1-17, 2016 | 52 | 2016 |
| Psychosis in Alzheimer’s disease C Ballard, HC Kales, C Lyketsos, D Aarsland, B Creese, R Mills, ... Current neurology and neuroscience reports 20, 1-10, 2020 | 47 | 2020 |
| Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease B Creese, E Vassos, S Bergh, L Athanasiu, I Johar, A Rongve, ... Translational psychiatry 9 (1), 273, 2019 | 47 | 2019 |
| Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease MAA DeMichele-Sweet, L Klei, B Creese, JC Harwood, EA Weamer, ... Molecular psychiatry 26 (10), 5797-5811, 2021 | 42 | 2021 |
| Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status M Ghahremani, EE Smith, HY Chen, B Creese, Z Goodarzi, Z Ismail Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 15 (1 …, 2023 | 39 | 2023 |
| Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCT. CA Surr, I Holloway, REA Walwyn, AW Griffiths, D Meads, R Kelley, ... Health Technology Assessment (Winchester, England) 24 (16), 1, 2020 | 34 | 2020 |
| A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in … C Ballard, A Thomas, S Gerry, LM Yu, D Aarsland, C Merritt, A Corbett, ... Journal of the American Medical Directors Association 16 (4), 316-322, 2015 | 33 | 2015 |
